Biohaven (BHVN) Tax Provisions (2021 - 2026)
Biohaven (BHVN) reported Tax Provisions of $272000.0 for Q1 2026, down 55.34% on a YoY basis from $609000.0 in Q1 2025, and down 22.51% sequentially from $351000.0 in Q4 2025.
Biohaven (BHVN) Tax Provisions (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Tax Provisions data on file, last reported at $272000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 55.34% year-over-year to $272000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 42.58% YoY), and the FY2025 full-year result was $1.4 million, up 96.19% from the prior year.
- Tax Provisions declined to $272000.0 in Q1 2026, from $351000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $7.3 million in Q1 2022 to a low of -$14.1 million in Q4 2022.
- A 5-year average of $88470.6 and a median of $272000.0 in 2026 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions sank 675.62% in 2022 and soared 631.25% in 2025, its largest moves.
- Tracing BHVN's Tax Provisions over 5 years: stood at -$14.1 million in 2022, then jumped by 91.43% to -$1.2 million in 2023, then soared by 103.96% to $48000.0 in 2024, then soared by 631.25% to $351000.0 in 2025, then declined by 22.51% to $272000.0 in 2026.
- Business Quant data shows BHVN's Tax Provisions at $272000.0 in Q1 2026, $351000.0 in Q4 2025, and $221000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 272,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | 221,000.00 |
| Jun 30, 2025 | 261,000.00 |
| Mar 31, 2025 | 609,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | -59,000.00 |
| Jun 30, 2024 | 177,000.00 |
| Mar 31, 2024 | 569,000.00 |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | -3.29 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 939,000.00 |
| Dec 31, 2022 | -14.14 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 6.11 Mn |
| Mar 31, 2022 | 7.26 Mn |
| Dec 31, 2021 | 2.46 Mn |
| Sep 30, 2021 | -1.13 Mn |